It drives inflammation, insulin resistance, and cardiovascular disease risk far more than subcutaneous fat (the kind you can pinch)
Overall, these pilot study findings indicate the potential therapeutic liver metabolism and function benefits associated with oral administration of glutathione in individuals with early NAFLD without decompensated cirrhosis
In fact, 34% of our genotype 4 infected patients reported routes of infection other than IDU, confirming the importance of other transmission routes of genotype 4 infection in our study area
(PubMed) Clarke R, Bennett DA, Parish S, et al
doi: 10.1016/s0021-9258(19)40252-4 32 ZouYPalteMJDeikAALiHEatonJKWangWet al
Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: The SURMOUNT-4 randomized clinical trial